Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
About this Treatment: Autologous Blood and Marrow Transplantation
About Autologous Blood and Marrow Transplantation
The principle behind an autologous blood and marrow transplant (BMT) is to begin with high doses of chemotherapy to more aggressively treat cancer. After the high dose chemotherapy, you are infused with your previously collected and stored stem cells to help your blood counts recover from the high dose chemotherapy.
An autologous BMT is done for patients diagnosed with lymphoma, multiple myeloma, and germ cell tumors such as testicular cancer. Autologous BMT may be recommended, if the disease:
Didn’t improve or respond to the drug therapy
Returned after completing drug therapy (this is called recurrence)